R&D platform
Five major development platforms and a tiered product pipeline layout to support the long-term growth of enterprises.
Bacterial Vaccine Technology Platform
Virus Scalable Culturing Technology Platform
Formulation and Adjuvant Technology Platform
Gene Engineering Technology Platform
mRNA vaccine technology platform
Technological breakthrough
· Alzheimer's disease treatment vaccine
· Tumor mRNA vaccine
· Type II Herpes Simplex Virus mRNA Vaccine
·Universal influenza mRNA vaccine
· Broad-spectrum attenuated live influenza vaccine
Fill a domestic gap
· Live attenuated herpes zoster vaccine (available on the market)
· Intranasal Live Attenuated Influenza Vaccine (Lyophilized and Liquid Formulations)
· RSV mRNA vaccine
· Influenza Virus Split Vaccine (BK-01 Adjuvant)
·Trivalent Influenza Virus Split Vaccine (BK-01 Adjuvant)
Upgrade and replace
· Live attenuated varicella vaccine (already on the market)
· Natural Fully Human Anti-Rabies Virus Monoclonal Antibody CBB1 Injection
· All-human anti-tetanus toxin monoclonal antibody A82/B86 injection combination formulation
· Adsorbed acellular pertussis, diphtheria, and tetanus (three-component) combination vaccine
·Lyophilized Haemophilus influenzae type b conjugate vaccine and related combination vaccines
·Recombinant Herpes Zoster Vaccine (CHO Cells)
·Lyophilized Human Rabies Vaccine (Human Diploid Cell)
Copyright © Changchun BCHT Biotechnology Co.